Reliance Capital, the financial service arm of the Anil Dhirubhai Ambani Group, has already started the due diligence process and is expected to complete this by the end of this financial year.
Sources familiar with the developments say Reliance Capital is looking at a valuation close to what Nippon Life had given for taking 26 per cent stake in Reliance Life.
"We have shorlisted a few foreign investors. The Nippon Life deal has shown there is a lot of interest for the Indian insurance sector. Reliance General is expected to report profits this year and, hence, it should fetch good value," said a source close to the development.
In March, the Japanese major, Nippon Life Insurance Co, entered into a definitive agreement to acquire a 26 per cent stake in Reliance Life for Rs 3,062 crore (Rs 30.62 billion), the largest foreign direct investment in the Indian insurance sector.
Earlier this month, both Nippon Life and R-Cap signed another pact.
"Nippon Life will be evaluating collaboration opportunities, including a strategic partnership, across all R-Cap-promoted financial businesses," the companies said in a joint statement.
Going by this announcement, the most likely company is Osaka-based Aioi Nissay Dowa Insurance Company Limited, a subsidiary of Nippon Life.
When asked, Reliance Capital CEO Sam Ghosh declined any comment.
Interestingly, it is a complete reversal of strategy for Reliance Capital, as last year it had plans to merge Reliance General Insurance with Sundaram Alliance Insurance Company, a joint venture between the Sundaram Group and the England-based RSA, which owns 26
IRDA nod for Reliance Cap sale of 26% stake in insurance biz
Anil Ambani to head India-China CEOs Forum
DGCA to inspect Juhu airport
Industry wait for new bank licences may get longer
Dim sum bonds a taste of things to come